Prevalence of antibodoes against group B streptococcal capsular polysaccharides in healthy chinese neonates

Pediatric Infectious Disease Journal

Volumn 16, Issue 12, 1997, Pages 1179-1180

  Shen, Xuzhuang ^a   Yang, Yonghong ^a   Zhang, Jinhua ^b   Berg, Stefan ^c   Lagergård, Teresa ^c   Trollfors, Birger ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antibodies; Cord blood; Group B streptococci; Prevalence

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL MEMBRANE; CHINA; CHINESE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INCIDENCE; NEWBORN; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SWEDEN; UMBILICAL CORD BLOOD; BLOOD; IMMUNOLOGY;

ANTIBODIES, BACTERIAL; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS AGALACTIAE;

EID: 0031283003     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199712000-00016     Document Type: Article

References (13)

1. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease: risk factors, prevention strategies, and vaccine development. Epidemiol Rev 1994;16:374-402.
2. Tessin I, Trollfors B, Thiringer K. Incidence and etiology of neonatal septicaemia and meningitis in western Sweden 1975-1986. Acta Paediatr Scand 1990;79:1023-30.
3. Vesikari T, Janas M, Grönroos P, et al. Neonatal septicaemia. Arch Dis Child 1985;60:542-6.
4. Aavitsland, P Hoiby EA, Lystad A. Systemic group B streptococcal disease in neonates and young infants in Norway 1985-94. Acta Paediatr 1996;85:104-5.
5. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6.
6. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infections. Paediatrics 1981;68:554-9.
7. Walsh JA, Hutchins S. Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J 1989;8:271-6.
8. Schuchat A. Group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 1995;49:19-25.
9. Cheng AFB, Fok TF, Duthie R, French L. A five-year prospective study of septicaemia in hospitalized children in Hong Kong. J Trop Med Hyg 1991;94:295-303.
10. Zhang JH, Yuan L, Yang YH, et al. Perinatal colonization of group B Streptococcus: a study in 600 cases in Beijing Tiantin hospital. Chin J Epidemiol 1995;16:36-9.
11. Lagergård T, Shiloach J, Robbins JB, Schneerson R. Synthesis and immunological properties of conjugates composed of group B Streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Infect Immun 1990;58:687-94.
12. Basham L, Pavliak V, Li X, et al. A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B Streptococcus type-specific antibodies in humans. Vaccine 1996;14:439-45.
13. Lau YL, Jones BM, Ng KW, Yeung CY, et al. Percentile ranges for serum IgG subclass concentrations in healthy Chinese children. Clin Exp Immunol 1993;91:337-41.